Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Impacts of Achieving Sustained Virological Response in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals

NCT03884062 is registered in ClinicalTrials.gov with Egyptian Liver Hospital as lead sponsor.

NCT NCT03884062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03884062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Impacts of Achieving Sustained Virological Response in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals
Lead sponsor
Egyptian Liver Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2015
Completion date
January 1, 2019
Enrollment
3,000 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hcc in chronic hcv patients with advanced liver fibrosis